| ISS 16-24 | ISS 25-34 | ISS 35-49 | ISS 50-75 | P value for all 4 group differences |
---|---|---|---|---|---|
Patients n (% of total) | 242 (35.9%) | 249 (36.9%) | 97 (14.4%) | 87 (12.9%) | N/A |
Age (range) | 42.5 (26-56) | 47 (29.5-60)ns | 45 (24-59)ns | 42 (25-59)ns | nsKruskal- Wallis |
Male n (% of ISS group) | 200 (82.6%) | 195 (78.3%)ns | 76 (78.4%)ns | 66 (75.9%)ns | nsChi-square |
Mortality n (% of ISS group) | 5 (2.1%) | 32 (12.9%)*** | 27 (27.8%)** | 42 (48.3%)** | ***Chi-square |
FIB mg/dL (IQR) | 235 (182.5-286.3) | 191.0 (143-240)*** | 134 (94.5-185.5)*** | 114 (69-156)* | ***Kruskal- Wallis |
Hb g/dL (IQR) | 13.0 (11.7-14.2) | 12.3 (10.6-13.7)*** | 10.9 (8.4-13.0)*** | 9.6 (7.0-11.6)** | ***Kruskal- Wallis |
BE mmol/L (IQR) | −2.6 (−4.5 to −1.4) | −3.7 (−6.2 to −2.1)*** | −5.7 (−8.5 to −2.9)*** | −7.1 (−10.9 to −4.6)** | ***Kruskal- Wallis |